1	AstraZeneca	astrazeneca	NNP	_	2	nsubj	2:A0=PAG
2	rejected	reject	VBD	pb=reject.01	0	root	_
3	Pfizer	pfizer	NNP	_	6	poss	_
4	's	's	POS	_	3	possessive	_
5	fourth	#ord#	JJ	_	6	amod	_
6	offer	offer	NN	_	2	dobj	2:A1=PPT
7	,	,	,	_	6	punct	_
8	all	all	DT	p2=RB	9	advmod	_
9	but	but	IN	p2=CC	6	prep	_
10	ending	end	VBG	pb=end.01	9	pcomp	_
11	the	the	DT	_	12	det	_
12	latter	latter	NN	p2=JJ	15	poss	_
13	's	's	POS	_	12	possessive	_
14	takeover	takeover	NN	_	15	nn	_
15	bid	bid	NN	_	10	dobj	10:A1=PPT
16	of	of	IN	_	15	prep	_
17	the	the	DT	_	20	det	_
18	U.K.	u.k.	NNP	_	20	nn	_
19	drug	drug	NN	_	20	nn	_
20	maker	maker	NN	_	16	pobj	_
21	.	.	.	_	2	punct	_

1	LONDON	london	NNP	_	6	npadvmod	_
2	,	,	,	_	6	punct	_
3	May	may	NNP	_	6	npadvmod	_
4	19	0	CD	_	3	num	_
5	(	(	-LRB-	_	6	punct	_
6	UPI	upi	NNP	_	0	root	_
7	)	)	-RRB-	_	6	punct	_
8	--	--	:	_	6	punct	_
9	AstraZeneca	astrazeneca	NNP	_	10	nsubj	10:A0=PAG;16:A0
10	rejected	reject	VBD	pb=reject.01	0	root	_
11	another	another	DT	_	12	det	_
12	offer	offer	NN	_	10	dobj	10:A1=PPT
13	from	from	IN	_	10	prep	10:A3=PRD
14	Pfizer	pfizer	NNP	_	13	pobj	_
15	,	,	,	_	10	punct	_
16	saying	say	VBG	pb=say.01	10	advcl	10:AM-ADV
17	the	the	DT	_	18	det	_
18	price	price	NN	_	19	nsubj	23:A0=PAG;19:A1=PPT
19	was	be	VBD	pb=be.01	16	ccomp	16:A1=PPT
20	too	too	RB	_	21	advmod	_
21	low	low	JJ	_	19	acomp	19:A2=PRD
22	and	and	CC	_	19	cc	_
23	ending	end	VBG	pb=end.01	19	conj	_
24	all	all	DT	_	25	det	_
25	chances	chance	NNS	_	23	dobj	23:A1=PPT
26	of	of	IN	_	25	prep	_
27	creating	create	VBG	pb=create.01	26	pcomp	_
28	the	the	DT	_	29	det	_
29	world	world	NN	_	33	poss	_
30	's	's	POS	_	29	possessive	_
31	biggest	big	JJS	_	33	amod	_
32	drug	drug	NN	_	33	nn	_
33	maker	maker	NN	_	27	dobj	27:A1=PPT
34	.	.	.	_	10	punct	_

1	The	the	DT	_	6	det	_
2	$	$	$	_	4	quantmod	_
3	117	0	CD	_	4	number	_
4	billion	#crd#	CD	_	6	nn	_
5	takeover	takeover	NN	p2=WDT	6	nn	_
6	offer	offer	NN	_	7	nsubj	7:A1=PPT
7	was	be	VBD	pb=be.01	0	root	_
8	Pfizer	pfizer	NNP	_	11	poss	_
9	's	's	POS	_	8	possessive	_
10	final	final	JJ	_	11	amod	_
11	offer	offer	NN	_	7	attr	7:A2=PRD
12	and	and	CC	_	7	cc	_
13	was	be	VBD	_	14	auxpass	_
14	rejected	reject	VBN	pb=reject.01	7	conj	_
15	by	by	IN	_	14	agent	14:A0=PAG
16	the	the	DT	_	19	det	_
17	U.K.	u.k.	NNP	_	19	nn	_
18	drug	drug	NN	_	19	nn	_
19	maker	maker	NN	_	15	pobj	_
20	,	,	,	_	14	punct	_
21	as	as	IN	_	23	mark	_
22	it	it	PRP	_	23	nsubj	23:A1=PAG;25:A1=PPT
23	failed	fail	VBD	pb=fail.01	14	advcl	14:AM-TMP
24	to	to	TO	_	25	aux	_
25	take	take	VB	pb=take.01	23	xcomp	23:A2=PPT
26	into	into	IN	_	25	prep	25:A2=DIR
27	account	account	NN	_	29	nn	_
28	experimental	experimental	JJ	_	29	amod	_
29	drugs	drug	NNS	_	26	pobj	_
30	in	in	IN	_	25	prep	25:AM-LOC
31	its	its	PRP$	_	32	poss	_
32	pipeline	pipeline	NN	_	30	pobj	_
33	and	and	CC	_	23	cc	_
34	also	also	RB	_	36	advmod	_
35	the	the	DT	_	36	det	_
36	risks	risk	NNS	_	23	conj	38:A1=PPT
37	it	it	PRP	_	38	nsubj	38:A0=PAG
38	presented	present	VBD	pb=present.01	36	rcmod	_
39	to	to	IN	_	38	prep	38:A2=GOL
40	shareholders	shareholder	NNS	_	39	pobj	_
41	.	.	.	_	7	punct	_

1	The	the	DT	_	2	det	_
2	deal	deal	NN	_	3	nsubj	3:A0
3	valued	value	VBN	p2=VBD|pb=value.01	0	root	_
4	AstraZeneca	astrazeneca	NNP	_	3	dobj	3:A1
5	at	at	IN	_	3	prep	3:A2=PRD
6	$	$	$	_	7	nmod	_
7	92	0	CD	_	5	pobj	_
8	per	per	IN	_	7	prep	_
9	share	share	NN	_	8	pobj	_
10	,	,	,	_	3	punct	_
11	but	but	CC	_	3	cc	_
12	the	the	DT	_	13	det	_
13	company	company	NN	_	14	nsubj	14:A0
14	said	say	VBD	pb=say.01	3	conj	_
15	something	something	NN	_	23	nsubj	23:A0=PAG
16	closer	close	JJR	p2=RBR	19	advmod	_
17	to	to	IN	_	19	quantmod	_
18	$	$	$	_	19	quantmod	_
19	98	0	CD	_	23	nsubj	_
20	per	per	IN	_	19	prep	_
21	share	share	NN	_	20	pobj	_
22	would	would	MD	_	23	aux	23:AM-MOD
23	represent	represent	VB	pb=represent.01	14	ccomp	14:A1=PPT
24	the	the	DT	_	26	det	_
25	true	true	JJ	_	26	amod	_
26	value	value	NN	_	23	dobj	23:A1=PPT
27	of	of	IN	_	26	prep	_
28	the	the	DT	_	29	det	_
29	company	company	NN	_	27	pobj	_
30	.	.	.	_	14	punct	_

1	"	"	``	p2=''	25	punct	_
2	From	from	IN	_	25	prep	25:AM-TMP
3	our	our	PRP$	_	5	poss	_
4	first	#ord#	JJ	_	5	amod	_
5	meeting	meeting	NN	_	2	pobj	_
6	in	in	IN	_	5	prep	_
7	January	january	NNP	_	6	pobj	_
8	to	to	IN	_	2	prep	_
9	our	our	PRP$	_	11	poss	_
10	latest	late	JJS	_	11	amod	_
11	discussion	discussion	NN	_	8	pobj	_
12	yesterday	yesterday	NN	_	2	npadvmod	_
13	,	,	,	_	2	punct	_
14	and	and	CC	_	2	cc	_
15	in	in	IN	_	25	prep	25:AM-LOC
16	the	the	DT	_	19	det	_
17	numerous	numerous	JJ	_	19	amod	_
18	phone	phone	NN	_	19	nn	_
19	calls	call	NNS	p2=VBZ	15	pobj	_
20	in	in	IN	p2=RP	19	prep	_
21	between	between	IN	p2=NN	19	prep	_
22	,	,	,	_	25	punct	_
23	Pfizer	pfizer	NNP	_	25	nsubj	27:A0=PAG;25:A1=PAG
24	has	have	VBZ	_	25	aux	_
25	failed	fail	VBN	pb=fail.01	0	root	_
26	to	to	TO	_	27	aux	_
27	make	make	VB	pb=make.02	25	xcomp	25:A2=PPT
28	a	a	DT	_	35	det	_
29	compelling	compelling	JJ	_	35	amod	_
30	strategic	strategic	JJ	_	35	amod	_
31	,	,	,	_	30	punct	_
32	business	business	NN	_	35	nn	_
33	or	or	CC	_	32	cc	_
34	value	value	NN	_	32	conj	_
35	case	case	NN	_	27	dobj	27:A1=PRD
36	.	.	.	_	25	punct	_

1	The	the	DT	_	2	det	_
2	Board	board	NNP	p2=NN	3	nsubj	3:A1=PPT
3	is	be	VBZ	pb=be.01	19	ccomp	19:A1=PPT
4	firm	firm	JJ	p2=RB	3	acomp	3:A2=PRD
5	in	in	IN	_	4	prep	_
6	its	its	PRP$	_	7	poss	_
7	conviction	conviction	NN	_	5	pobj	_
8	as	as	IN	p2=RB	7	prep	_
9	to	to	IN	_	8	prep	_
10	the	the	DT	_	12	det	_
11	appropriate	appropriate	JJ	_	12	amod	_
12	terms	term	NNS	_	9	pobj	_
13	to	to	TO	_	14	aux	_
14	recommend	recommend	VB	pb=recommend.01	12	infmod	_
15	to	to	IN	_	14	prep	14:A2=GOL
16	shareholders	shareholder	NNS	_	15	pobj	_
17	,	,	,	_	19	punct	_
18	"	"	''	_	19	punct	_
19	said	say	VBD	pb=say.01	0	root	_
20	AstraZeneca	astrazeneca	NNP	_	21	nn	_
21	Chairman	chairman	NNP	_	23	nn	_
22	Leif	leif	NNP	_	23	nn	_
23	Johansson	johansson	NNP	_	19	nsubj	19:A0
24	.	.	.	_	19	punct	_

1	He	he	PRP	_	2	nsubj	2:A0=PAG
2	added	add	VBD	pb=add.01	0	root	_
3	that	that	IN	_	6	complm	_
4	the	the	DT	_	5	det	_
5	offer	offer	NN	_	6	nsubj	6:A1=PPT
6	was	be	VBD	pb=be.01	2	ccomp	2:A1=PPT
7	a	a	DT	_	9	det	_
8	minor	minor	JJ	_	9	amod	_
9	improvement	improvement	NN	_	6	attr	6:A2=PRD
10	upon	upon	IN	_	9	prep	_
11	Pfizer	pfizer	NNP	_	14	poss	_
12	's	's	POS	_	11	possessive	_
13	third	#ord#	JJ	p2=RB	14	amod	_
14	offer	offer	NN	_	10	pobj	_
15	,	,	,	_	2	punct	_
16	but	but	CC	_	2	cc	_
17	still	still	RB	_	18	advmod	18:AM-TMP
18	continued	continue	VBD	pb=continue.01	2	conj	_
19	to	to	TO	_	21	aux	_
20	"	"	``	_	21	punct	_
21	fall	fall	VB	pb=fall.01	18	xcomp	18:C-A1
22	short	short	RB	p2=JJ	21	advmod	21:A4=GOL
23	of	of	IN	_	22	prep	_
24	the	the	DT	_	25	det	_
25	Board	board	NNP	_	27	poss	_
26	's	's	POS	_	25	possessive	_
27	view	view	NN	_	23	pobj	_
28	of	of	IN	_	27	prep	_
29	value	value	NN	_	28	pobj	_
30	and	and	CC	_	18	cc	_
31	has	have	VBZ	_	33	aux	_
32	been	be	VBN	_	33	auxpass	_
33	rejected	reject	VBN	pb=reject.01	18	conj	_
34	.	.	.	_	2	punct	_
35	"	"	''	_	2	punct	_

1	The	the	DT	_	2	det	_
2	deal	deal	NN	_	12	nsubj	5:A0=PAG;12:A0
3	,	,	,	_	2	punct	_
4	which	which	WDT	_	5	nsubj	5:R-A0
5	looks	look	VBZ	pb=look.02	2	rcmod	_
6	like	like	IN	_	8	mark	_
7	it	it	PRP	_	8	nsubj	8:A1=PPT
8	is	be	VBZ	pb=be.01	5	advcl	5:A1=PPT
9	dead	dead	JJ	_	8	acomp	8:A2=PRD
10	,	,	,	_	14	punct	_
11	had	have	VBD	p2=VBN	12	aux	_
12	split	split	VBN	p2=JJ|pb=split.01	0	root	_
13	AstraZeneca	astrazeneca	NNP	_	14	nn	_
14	shareholders	shareholder	NNS	_	12	dobj	12:A1=PPT
15	,	,	,	_	12	punct	_
16	with	with	IN	_	12	prep	12:AM-MNR
17	many	many	JJ	_	18	nsubj	18:A0=PAG
18	suggesting	suggest	VBG	p2=NN|pb=suggest.01	16	pcomp	_
19	that	that	IN	_	23	complm	_
20	the	the	DT	_	21	det	_
21	board	board	NN	_	23	nsubj	23:A0=PAG;30:A0=PAG
22	was	be	VBD	_	23	aux	_
23	making	make	VBG	pb=make.02	18	ccomp	18:A1=PPT
24	a	a	DT	_	27	det	_
25	"	"	``	_	27	punct	_
26	gross	gross	JJ	_	27	amod	_
27	miscalculation	miscalculation	NN	_	23	dobj	23:A1=PRD
28	"	"	''	_	27	punct	_
29	in	in	IN	_	23	prep	_
30	rejecting	reject	VBG	pb=reject.01	29	pcomp	_
31	the	the	DT	_	32	det	_
32	offer	offer	NN	_	30	dobj	30:A1=PPT
33	.	.	.	_	12	punct	_

1	They	they	PRP	_	3	nsubj	3:A0=PAG
2	also	also	RB	_	3	advmod	3:AM-DIS
3	felt	feel	VBD	pb=feel.02	0	root	_
4	that	that	IN	_	9	complm	_
5	the	the	DT	_	6	det	_
6	company	company	NN	_	9	nsubj	9:A0=PAG;16:A0=PAG
7	should	should	MD	_	9	aux	9:AM-MOD
8	have	have	VB	_	9	aux	_
9	engaged	engage	VBN	pb=engage.01	3	ccomp	3:A1=PPT
10	in	in	IN	_	9	prep	9:A2=PPT
11	constructive	constructive	JJ	_	12	amod	_
12	talks	talk	NNS	_	10	pobj	_
13	with	with	IN	_	12	prep	_
14	Pfizer	pfizer	NNP	_	13	pobj	_
15	to	to	TO	_	16	aux	_
16	reach	reach	VB	pb=reach.01	9	advcl	_
17	an	an	DT	_	19	det	_
18	acceptable	acceptable	JJ	_	19	amod	_
19	figure	figure	NN	_	16	dobj	16:A1=GOL
20	.	.	.	_	3	punct	_

1	©	©	NFP	p2=NNP	7	punct	_
2	2014	0	CD	_	5	num	_
3	United	united	NNP	_	5	nn	_
4	Press	press	NNP	_	5	nn	_
5	International	international	NNP	_	7	nn	_
6	,	,	,	_	7	punct	_
7	Inc	inc	NNP	_	0	root	_
8	.	.	.	_	7	punct	_

1	All	all	DT	p2=PDT	3	det	_
2	Rights	right	NNPS	p2=NNS	3	nn	3:A0
3	Reserved	reserved	VBD	p2=VBD|pb=reserve.01	0	root	_
4	.	.	.	_	3	punct	_

1	Any	any	DT	_	2	det	_
2	reproduction	reproduction	NN	_	17	nsubjpass	17:A1=PPT
3	,	,	,	_	2	punct	_
4	republication	republication	NN	_	2	conj	_
5	,	,	,	_	4	punct	_
6	redistribution	redistribution	NN	_	4	conj	_
7	and	and	CC	_	6	cc	_
8	/	/	SYM	_	7	punct	_
9	or	or	CC	_	7	cc	_
10	modification	modification	NN	_	6	conj	_
11	of	of	IN	_	10	prep	_
12	any	any	DT	_	14	det	_
13	UPI	upi	NNP	p2=JJ	14	nn	_
14	content	content	NN	_	11	pobj	_
15	is	be	VBZ	_	17	auxpass	_
16	expressly	expressly	RB	_	17	advmod	17:AM-MNR
17	prohibited	prohibit	VBN	pb=prohibit.01	0	root	_
18	without	without	IN	_	17	prep	17:AM-MNR
19	UPI	upi	NNP	_	23	poss	_
20	's	's	POS	_	19	possessive	_
21	prior	prior	JJ	p2=RB	23	amod	_
22	written	write	VBN	p2=JJ|pb=write.01	23	amod	_
23	consent	consent	NN	_	18	pobj	22:A1=PPT
24	.	.	.	_	17	punct	_

1	UPI	upi	NNP	p2=NN	2	nn	_
2	licenses	license	NNS	p2=VBZ	3	nsubj	3:A1=PPT
3	content	content	VBP	p2=NN|pb=content.01	0	root	_
4	directly	directly	RB	_	3	advmod	3:AM-MNR
5	to	to	IN	p2=TO	3	prep	3:A2=MNR
6	print	print	NN	p2=JJ	7	nn	_
7	outlets	outlet	NNS	_	5	pobj	_
8	,	,	,	_	7	punct	_
9	online	online	JJ	p2=NN	10	amod	_
10	media	medium	NNS	_	7	conj	_
11	and	and	CC	_	10	cc	_
12	institutions	institution	NNS	_	10	conj	_
13	of	of	IN	_	7	prep	_
14	all	all	DT	_	15	det	_
15	types	type	NNS	_	13	pobj	_
16	.	.	.	_	3	punct	_

1	In	in	IN	_	8	prep	8:AM-DIS
2	addition	addition	NN	_	1	pobj	_
3	,	,	,	_	8	punct	_
4	UPI	upi	NNP	_	7	poss	_
5	's	's	POS	_	4	possessive	_
6	distribution	distribution	NN	_	7	nn	_
7	partners	partner	NNS	_	8	nsubj	8:A0=PAG
8	provide	provide	VBP	p2=VB|pb=provide.01	0	root	_
9	our	our	PRP$	_	10	poss	_
10	content	content	NN	_	8	dobj	8:A1=PPT
11	to	to	IN	_	8	prep	8:A2=GOL
12	thousands	#crd#	NNS	_	11	pobj	_
13	of	of	IN	_	12	prep	_
14	businesses	business	NNS	_	13	pobj	_
15	,	,	,	_	14	punct	_
16	policy	policy	NN	_	17	nn	_
17	groups	group	NNS	_	14	conj	_
18	and	and	CC	_	17	cc	_
19	academic	academic	JJ	_	20	amod	_
20	institutions	institution	NNS	_	17	conj	_
21	worldwide	worldwide	RB	_	8	advmod	_
22	.	.	.	_	8	punct	_

1	Our	our	PRP$	_	2	poss	_
2	audience	audience	NN	_	3	nsubj	3:A1=PPT
3	consists	consist	VBZ	pb=consist.01	0	root	_
4	of	of	IN	_	3	prep	3:A2=VSP
5	millions	#crd#	NNS	_	4	pobj	_
6	of	of	IN	_	5	prep	_
7	decision	decision	NN	_	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	makers	maker	NNS	_	6	pobj	11:A0=PAG
10	who	who	WP	_	11	nsubj	11:R-A0
11	depend	depend	VBP	pb=depend.01	9	rcmod	_
12	on	on	IN	_	11	prep	11:A1=PPT
13	UPI	upi	NNP	_	18	poss	_
14	's	's	POS	_	13	possessive	_
15	insightful	insightful	JJ	_	18	amod	_
16	and	and	CC	_	15	cc	_
17	analytical	analytical	JJ	_	15	conj	_
18	stories	story	NNS	_	12	pobj	_
19	to	to	TO	_	20	aux	_
20	make	make	VB	pb=make.01	11	advcl	11:AM-PRP
21	better	good	JJR	_	25	amod	_
22	business	business	NN	_	25	nn	_
23	or	or	CC	_	22	cc	_
24	policy	policy	NN	_	22	conj	_
25	decisions	decision	NNS	_	20	dobj	20:AM-PRR
26	.	.	.	_	3	punct	_

1	In	in	IN	_	11	prep	11:AM-TMP
2	the	the	DT	_	3	det	_
3	year	year	NN	_	1	pobj	_
4	of	of	IN	_	3	prep	_
5	our	our	PRP$	_	7	poss	_
6	107th	#ord#	JJ	_	7	amod	_
7	anniversary	anniversary	NN	_	4	pobj	_
8	,	,	,	_	11	punct	_
9	our	our	PRP$	_	10	poss	_
10	company	company	NN	_	11	nsubj	11:A0=PAG;13:A0=PAG
11	strives	strive	VBZ	pb=strive.01	0	root	_
12	to	to	TO	_	13	aux	_
13	continue	continue	VB	pb=continue.01	11	xcomp	11:A1=PPT
14	being	be	VBG	_	18	auxpass	_
15	a	a	DT	_	16	det	_
16	leading	lead	VBG	p2=NN|pb=lead.01	18	nsubjpass	_
17	and	and	CC	_	16	cc	_
18	trusted	trust	VBN	p2=VBD|pb=trust.02	6	conj	_
19	source	source	NN	_	18	dobj	18:A1=PAG
20	for	for	IN	_	19	prep	_
21	news	news	NN	_	20	pobj	_
22	,	,	,	_	21	punct	_
23	analysis	analysis	NN	_	21	conj	_
24	and	and	CC	_	23	cc	_
25	insight	insight	NN	_	23	conj	_
26	for	for	IN	_	25	prep	_
27	readers	reader	NNS	_	26	pobj	_
28	around	around	IN	_	27	prep	_
29	the	the	DT	_	30	det	_
30	world	world	NN	_	28	pobj	_
31	.	.	.	_	11	punct	_

1	©	©	NFP	p2=NNP	7	punct	_
2	2014	0	CD	_	5	num	_
3	United	united	NNP	_	5	nn	_
4	Press	press	NNP	_	5	nn	_
5	International	international	NNP	_	7	nn	_
6	,	,	,	_	7	punct	_
7	Inc	inc	NNP	_	0	root	_
8	.	.	.	_	7	punct	_

1	All	all	DT	p2=PDT	3	det	_
2	Rights	right	NNPS	p2=NNS	3	nn	3:A0
3	Reserved	reserved	VBD	p2=VBD|pb=reserve.01	0	root	_
4	.	.	.	_	3	punct	_

1	UPI.com	#url#	ADD	_	2	nsubj	2:A1=PPT
2	is	be	VBZ	pb=be.01	0	root	_
3	your	your	PRP$	_	5	poss	_
4	trusted	trust	VBN	p2=JJ|pb=trust.02	5	amod	_
5	source	source	NN	_	2	attr	4:A1=PAG;2:A2=PRD
6	for	for	IN	_	5	prep	_
7	world	world	NN	_	8	nn	_
8	news	news	NN	_	6	pobj	_
9	,	,	,	_	5	punct	_
10	top	top	JJ	p2=NN	11	amod	_
11	news	news	NN	_	5	appos	_
12	,	,	,	_	5	punct	_
13	science	science	NN	_	14	nn	_
14	news	news	NN	_	5	appos	_
15	,	,	,	_	5	punct	_
16	health	health	NN	_	17	nn	_
17	news	news	NN	_	5	appos	_
18	and	and	CC	_	17	cc	_
19	current	current	JJ	_	20	amod	_
20	events	event	NNS	_	17	conj	_
21	.	.	.	_	2	punct	_

1	We	we	PRP	_	2	nsubj	2:A0=PAG
2	thank	thank	VBP	pb=thank.01	0	root	_
3	you	you	PRP	_	2	dobj	5:A0=PAG;2:A1=PPT
4	for	for	IN	_	2	prep	2:A2=CAU
5	visiting	visit	VBG	pb=visit.01	4	pcomp	_
6	us	us	PRP	_	5	dobj	5:A1=COM
7	and	and	CC	_	2	cc	_
8	we	we	PRP	_	9	nsubj	9:A0
9	hope	hope	VBP	pb=hope.01	2	conj	_
10	that	that	IN	_	13	complm	_
11	we	we	PRP	_	13	nsubj	13:A1=PPT
12	will	will	MD	_	13	aux	13:AM-MOD
13	be	be	VB	pb=be.01	9	ccomp	9:A1=PPT
14	your	your	PRP$	_	16	poss	_
15	daily	daily	JJ	_	16	amod	_
16	stop	stop	NN	p2=VB	13	attr	13:A2=PRD
17	for	for	IN	_	16	prep	_
18	news	news	NN	_	19	nn	_
19	updates	update	NNS	_	17	pobj	_
20	.	.	.	_	9	punct	_

